{
  "retracted": false,
  "timestamp": 1338508800000,
  "updates": [
    {
      "timestamp": 1555701059520,
      "identifier": {
        "doi": "10.1038/nrd3778"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/nrd3750"
  },
  "journal": "Nature Reviews Drug Discovery",
  "publisher": "Springer Nature",
  "title": "Erratum: Busy panels recommend Pfizer's tofacitinib, Arena's lorcaserin and more"
}
